GLOBAL CONTRACEPTIVE MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL CONTRACEPTIVE MARKET FORECAST 2019-2027

GLOBAL CONTRACEPTIVE MARKET FORECAST 2019-2027

The global contraceptive market was valued at $24202.12 million in 2018 & is estimated to generate net revenue of approximately $44010.44 million by 2027, growing at a CAGR of 6.96%. The contraceptive is the use of a device, or drugs for preventing pregnancy, the transmission of sexually transmitted infections, and birth control & family planning.

 

GLOBAL CONTRACEPTIVE MARKET FORECAST 2019-2027

Global Contraceptive Market by Education (Less Than High School, High School Graduate, College Graduate, Other College Degrees) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End-user (Households, Clinics, Hospitals) by Drugs and Devices (Contraceptives Drugs, Contraceptive Devices) by Geography.

Request free sample

The global contraceptive market was valued at $24202.12 million in 2018 & is estimated to generate net revenue of approximately $44010.44 million by 2027, growing at a CAGR of 6.96%. The contraceptive is the use of a device, or drugs for preventing pregnancy, the transmission of sexually transmitted infections, and birth control & family planning. The following factors primarily drive the contraceptive market:

  • Rising customer awareness and government initiatives
  • The growing incidence of unwanted pregnancies
  • The swelling occurrence of sexually transmitted diseases (STD)

The important drivers that are propelling the growth in the global contraceptive market are rising customer awareness and government initiatives & growing incidence of unwanted pregnancies. The improving economies, customer awareness levels are constantly rising, which is expected to elevate the impact to a high level over the forecast period. Despite the overall increase in the use of contraceptives worldwide, approximately 233 million women of the reproductive age by 2015 are estimated to have unmet needs for family planning methods which is expected to have a high impact on the market over the forecast period.

Contraceptive drugs & devices are used extensively for various purposes. The contraceptive drugs comprise of oral contraceptive pills, injectable contraceptives, and topical contraceptives whereas contraceptive devices are male condoms, female condoms, diaphragms, contraceptive sponges, vaginal rings, subdermal implants, and intra-uterine devices. These pills are highly effective drugs used for preventing unwanted and unplanned pregnancy, and for regularizing periods. Some of them are administered orally and contain hormones such as estrogen and progestin, which can block ovum development and ovulation. Contraceptive devices are more effective, safe, convenient, and easy to use as compared to drugs. Globally, male condoms are widely accepted and the most commonly used form of barrier contraceptive that prevents the sperm from entering the uterus. Government and NGO’s initiatives have increased the awareness levels of the citizens, which are expected to boost the condoms market over the forecast period.

Increasing aging population and side effects associated with the use of contraceptive drugs and devices are the major factors hindering the contraceptive market. Growing aging population is a major restraint of the contraceptives market. The side effects have led to the popularity of traditional contraceptive methods such as tubal ligation, vasectomy, withdrawal, and abstinence.

The global contraceptive market segments include education, age group, end user and drugs & devices:

Education is segmented into:

  • Less than high school
  • High school graduate
  • College graduate
  • Other college degrees

Age group is segmented into:

  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years

End-user is segmented into

  • Households
  • Clinics
  • Hospitals

Drugs & devices is segmented into

  • Contraceptives drugs
    • Oral contraceptive pills
    • Injectable contraceptives
    • Topical contraceptives
  • Contraceptive devices
    • Male condoms
    • Female condoms
    • Diaphragms
    • Contraceptive sponges
    • Vaginal rings
    • Subdermal implants
    • Intra-uterine devices
      • Copper intra-uterine devices
      • Hormonal intra-uterine devices

This report covers the present market conditions and the growth prospects of the global contraceptive market for 2019-2027 and considered the revenue generated through the sales of contraceptive for education, age group, end-user and drugs & devices to calculate the market size by considering 2018 as the base year.

Geographically, the global contraceptive market has been segmented on the basis of four major regions, which include:

The contraceptive market in North America is expected to hold the largest share by 2027 due to the possibilities of increased use of contraceptives. North America contraceptive market constitutes approx. 32% share. Growth in the North American contraceptives market was due to the rise in need to prevent unwanted pregnancies, increase in several government initiatives to avoid unwanted pregnancies and growth in the number of product innovations.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the contraceptive market. The Asia-Pacific contraceptives market is on a continuous rise due to the increase in the need for contraceptives in developing economies. The main challenge that has been reported in this region is providing sexual health information & services to an inappropriate population.

The contraceptive market is segmented based on education which is sub-divided into less than high school, high school graduate, college graduate and other college degrees, also segmented on the basis of age group which is sub-divided into 15–24 years, 25–34 years, 35–44 years and above 44 years and also segmented on the basis of end-user which is sub-divided into households, clinics and hospitals. Educated users are well aware of the recent contraception methods such as emergency contraceptives, contraceptive patches, and morning pills among others. The segment 15–24 years is the largest contributor for the growth of the contraceptives market and is anticipated to grow at the fastest rate, owing to the increase in need of contraceptive pills and condoms by teenagers. Contraceptive drugs and devices are used by a set of end-users to avoid pregnancy & STIs and for birth control & family planning. In this report, end-users comprise households, clinics, and hospitals.

The major market players of the global contraceptive market are:

  • Bayer Group
  • Pfizer
  • Merck & Co., Inc.
  • Agile Therapeutics
  • Teva Pharmaceutical Industries Ltd.

Company Profiles covers the analysis of important players. Bayer AG’s pharmaceuticals segment is engaged in the development of prescription pharmaceuticals, contraceptives and medical products such as injection systems and contrast agents for diagnostic procedures. TEVA Pharmaceutical Industries Ltd. has a widespread product portfolio in generic pharmaceutical products, specialized pharmaceuticals, and basic chemicals.

Key findings of the global contraceptive market:

  • College graduate holds the largest market share in terms of education
  • The age group of 15–24 years is anticipated to grow significantly
  • Households are the majorly used end user
  • Contraceptives devices are widely used
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • COLLEGE GRADUATE HOLDS THE LARGEST MARKET SHARE IN TERMS OF EDUCATION
      • AGE GROUP OF 15–24 YEARS IS ANTICIPATED TO GROW SIGNIFICANTLY
      • HOUSEHOLDS ARE THE MAJORLY USED END-USER
      • CONTRACEPTIVES DEVICES ARE WIDELY USED
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • RISING CUSTOMER AWARENESS AND GOVERNMENT INITIATIVES
      • GROWING INCIDENCE OF UNWANTED PREGNANCIES
      • OCCURRENCE OF SEXUALLY TRANSMITTED DISEASES (STD)
    • MARKET RESTRAINTS
      • INCREASING AGING POPULATION
      • SIDE EFFECTS ASSOCIATED WITH THE USE OF CONTRACEPTIVE DRUGS AND DEVICES
    • MARKET OPPORTUNITIES
      • INCREASE IN AWARENESS AND IMPORTANCE REGARDING FAMILY PLANNING
      • STRATEGIC ALLIANCES AND INVESTING IN R&D
    • MARKET CHALLENGES
      • LACK OF PERCEPTION OF SOCIETY
      • INCREASING COST AND INACCESSIBILITY OF CERTAIN HEALTH SERVICES
  1. MARKET BY EDUCATION
    • LESS THAN HIGH SCHOOL
    • HIGH SCHOOL GRADUATE
    • COLLEGE GRADUATE
    • OTHER COLLEGE DEGREES
  2. MARKET BY AGE GROUP
    • 15–24 YEARS
    • 25–34 YEARS
    • 35–44 YEARS
    • ABOVE 44 YEARS
  3. MARKET BY END-USER
    • HOUSEHOLDS
    • CLINICS
    • HOSPITALS
  4. MARKET BY DRUGS AND DEVICES
    • CONTRACEPTIVES DRUGS
      • ORAL CONTRACEPTIVE PILLS
      • INJECTABLE CONTRACEPTIVES
      • TOPICAL CONTRACEPTIVES
    • CONTRACEPTIVE DEVICES
      • MALE CONDOMS
      • FEMALE CONDOMS
      • DIAPHRAGMS
      • CONTRACEPTIVE SPONGES
      • VAGINAL RINGS
      • SUBDERMAL IMPLANTS
      • INTRA-UTERINE DEVICES
        • COPPER INTRA-UTERINE DEVICES
        • HORMONAL INTRA-UTERINE DEVICES
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • PESTEL ANALYSIS
    • REGULATORY FRAMEWORK
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AFAXYS, INC.
      • AGILE THERAPEUTICS
      • ALLERGAN INC.
      • APOTHECUS PHARMACEUTICAL CORPORATION
      • BAYER AG
      • CHURCH & DWIGHT CO., INC.
      • COOPER SURGICAL INC.
      • MAYER LABORATORIES, INC.
      • MERCK & CO., INC.
      • OCON MEDICAL LTD.
      • OKAMOTO INDUSTRIES, INC.
      • PFIZER, INC.
      • PREGNA
      • RECKITT BENCKISER PLC
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

TABLE LIST

TABLE 1        GLOBAL CONTRACEPTIVE MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 2        ASSOCIATED SIDE EFFECTS FOR DIFFERENT CONTRACEPTIVE METHOD

TABLE 3        GLOBAL CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL LESS THAN HIGH SCHOOL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL HIGH SCHOOL GRADUATE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL COLLEGE GRADUATE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL OTHER COLLEGE DEGREES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 9        GLOBAL 15–24 YEARS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL 25–34 YEARS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL 35–44 YEARS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL ABOVE 44 YEARS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL CONTRACEPTIVE MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 14      GLOBAL HOUSEHOLDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15      GLOBAL CLINICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL HOSPITALS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 18      GLOBAL CONTRACEPTIVES DRUGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 20      GLOBAL ORAL CONTRACEPTIVE PILLS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21      GLOBAL INJECTABLE CONTRACEPTIVESMARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22      GLOBAL TOPICAL CONTRACEPTIVESMARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      GLOBAL CONTRACEPTIVE DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      GLOBAL CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 25      GLOBAL MALE CONDOMS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26      GLOBAL FEMALE CONDOMS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 27      GLOBAL DIAPHRAGMS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 28      GLOBAL CONTRACEPTIVE SPONGES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 29      GLOBAL VAGINAL RINGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 30      GLOBAL SUBDERMAL IMPLANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 31      GLOBAL INTRA-UTERINE DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 32      GLOBAL INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 33      GLOBAL COPPER INTRA-UTERINE DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 34      GLOBAL HORMONAL INTRA-UTERINE DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 35      GLOBAL CONTRACEPTIVE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 36      NORTH AMERICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 37      THE UNITED STATES CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 38      CANADA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 39      EUROPE CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 40      GERMANY CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 41      FRANCE CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 42      THE UNITED KINGDOM CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 43      SPAIN CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 44      ITALY CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 45      ASIA PACIFIC CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 46      JAPAN CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 47      CHINA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 48      INDIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 49      AUSTRALIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 50      SOUTH KOREA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 51      REST OF WORLD CONTRACEPTIVE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 52      CONTRACEPTIVE COMPANY MARKET POSITION ANALYSIS 2017

 

FIGURE LIST          

FIGURE 1      GLOBAL CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL CONTRACEPTIVE MARKET SHARE BY EDUCATION 2018 & 2027 (%)

FIGURE 3      GLOBAL CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL CONTRACEPTIVE MARKET SHARE BY AGE GROUP 2018 & 2027 (%)

FIGURE 8      GLOBAL CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL CONTRACEPTIVE MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 13   GLOBAL CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL CONTRACEPTIVE MARKET SHARE BY DRUGS AND DEVICES 2018 & 2027 (%)

FIGURE 17   GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 31   PORTER’S FIVE FORCE MODEL

FIGURE 32   GLOBAL CONTRACEPTIVE MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 33   THE UNITED STATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 34   CANADA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 35   GERMANY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 36   FRANCE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 37   THE UNITED KINGDOM CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 38   SPAIN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 39   ITALY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 40   REST OF EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 41   JAPAN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 42   CHINA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 43   INDIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 44   AUSTRALIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 45   SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 46   REST OF ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 47   LATIN AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 48   MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

  1. MARKET BY EDUCATION
    • LESS THAN HIGH SCHOOL
    • HIGH SCHOOL GRADUATE
    • COLLEGE GRADUATE
    • OTHER COLLEGE DEGREES
  2. MARKET BY AGE GROUP
    • 15–24 YEARS
    • 25–34 YEARS
    • 35–44 YEARS
    • ABOVE 44 YEARS
  3. MARKET BY END-USER
    • HOUSEHOLDS
    • CLINICS
    • HOSPITALS
  4. MARKET BY DRUGS AND DEVICES
    • CONTRACEPTIVES DRUGS
      • ORAL CONTRACEPTIVE PILLS
      • INJECTABLE CONTRACEPTIVES
      • TOPICAL CONTRACEPTIVES
    • CONTRACEPTIVE DEVICES
      • MALE CONDOMS
      • FEMALE CONDOMS
      • DIAPHRAGMS
      • CONTRACEPTIVE SPONGES
      • VAGINAL RINGS
      • SUBDERMAL IMPLANTS
      • INTRA-UTERINE DEVICES
        • COPPER INTRA-UTERINE DEVICES
        • HORMONAL INTRA-UTERINE DEVICES
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now